Friday, July 28, 2017
IBB 322.06 2.27 (0.71%)XBI 79.80 1.06 (1.35%)CNCR 23.04 0.13 (0.58%)
Ticker Current Price Change Graph
IBB 322.06 2.27 (0.71%)
XBI 79.80 1.06 (1.35%)
CNCR 23.04 0.13 (0.58%)
Last updated: ago
Sign in to Endpoints
Menu Search Chat
  • Special Reports
  • Deep Dives
  • ENDPOINTS 100
  • News
  • Protocols
  • Bioregnum
  • Thumbs Up/Down
  • About
  • Advertise
  • Privacy Policy
  • Reader center

Merck admits cyberattack is having an impact on research, manufacturing — we’re just not sure how big

by Arsalan Arifenvelope — on July 28, 2017 11:27 AM EDT

Biotech billionaire Soon-Shiong picks up rights to CytRx’s troubled cancer drug

by John Carrollenvelope — on July 28, 2017 10:35 AM EDT
Updated: 11:16 AM

The global rivalry for top scientific talent in biopharma R&D is about to get a lot hotter

by John Carrollenvelope — on July 28, 2017 09:58 AM EDT
Updated: 10:00 AM

CheckMate-227: Bristol-Myers Squibb has a MYSTIC-sized problem on its hands

by John Carrollenvelope — on July 28, 2017 08:36 AM EDT
Updated: 10:41 AM

GSK’s Moncef Slaoui joins the board at Moderna; Aduro promotes van Elsas to CSO

by Shehla Shakoorenvelope — on July 27, 2017 11:40 PM EDT

J&J sews up an expanded vaccine pact with Bavarian Nordic, paying $43M for HIV, hep B projects

by John Carrollenvelope — on July 27, 2017 12:56 PM EDT

Tesaro partners with Takeda in Asia, bagging a $340M deal for Zejula

by John Carrollenvelope — on July 27, 2017 07:44 AM EDT

Alexion joins the R&D reorganization gala, pruning a slate of projects and revving up new deals

by John Carrollenvelope — on July 27, 2017 07:09 AM EDT
Updated: 07:53 AM

Sienna Bio bags $65M in the latest successful biotech IPO

by John Carrollenvelope — on July 27, 2017 06:55 AM EDT
Updated: 09:44 AM

UPDATED: Astellas is shuttering Agensys, axing 220 jobs and moving away from ADC tech

by Arsalan Arifenvelope — on July 27, 2017 04:18 AM EDT
Updated: 10:59 AM

  • 1
  • 2
  • 3
  • 164

Contact Endpoints News

You can also contact John Carroll, Editor at john@endpointsnews.com

← Go back
  • About
  • Privacy Policy
  • Media Kit

copyright 2017 Endpoints Company

Yes, I'd like to subscribe No, thanks
I'm already a subscriber
Thank you for staying with us. It's great to have you on board!
Aww, shucks. Perhaps you can tell us what we could do to make you interested in subscribing?
Sure No
← Go back

Sign-in with a magic link

One-time use, expires in minutes.